Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Postprocedural Susceptibility-Weighted Imaging and Vessel-Wall Imaging For Prediction of Complications After Flow-Diversion Treatment of Intracranial Aneurysms

NCT05716360 is registered in ClinicalTrials.gov with Uludag University as lead sponsor.

NCT NCT05716360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05716360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Postprocedural Susceptibility-Weighted Imaging and Vessel-Wall Imaging For Prediction of Complications After Flow-Diversion Treatment of Intracranial Aneurysms
Lead sponsor
Uludag University
Phase
Observational
Overall status
Unknown status
Start date
April 28, 2022
Completion date
April 28, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early susceptibility-weighted imaging and vessel-wall imaging findings after flow-diversion treatment of intracranial aneurysms